In 2025, medical billing services for small practices are seeing a rise in anemia-related claims, especially tied to chronic fatigue and routine bloodwork
In mice it blunted alcohol intoxication and prevented deadly withdrawal, and it seems to act through the gut-brain axis
J Virol 77:75397544
worsening the deficiency in SAM synthetase
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027